Home › Funds › BI Asset Management Fondsmaeglerselskab A/S › BMY

BI Asset Management Fondsmaeglerselskab A/S position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

BI Asset Management Fondsmaeglerselskab A/S reported holding 1,013,573 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$63.2M, representing 0.48% of its reported portfolio and ranking #33 among its reported holdings. BI Asset Management Fondsmaeglerselskab A/S has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.01M sh
Reported value held$63.25M
Portfolio Weight0.48%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BI Asset Management Fondsmaeglerselskab A/S's BMY position evolved

BI Asset Management Fondsmaeglerselskab A/S first disclosed a stake in BMY in Q3 2023 at 93,646 shares (US$5.4M). The position peaked in Q3 2026 at 1,013,573 shares, worth US$63.2M. Across 13 filings, BI Asset Management Fondsmaeglerselskab A/S increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,013,573 shares valued at US$63.2M — a reduction of -19,784 shares quarter over quarter.. Notable position changes include a 237% increase in Q4 2023 (shares rose 7% over the following quarter), a 166% increase in Q2 2025 (shares fell 1% over the following quarter), a 192% increase in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 93.65K $5.43M New
Q4 2023 315.27K $16.18M Add
Q1 2024 35.00K $1.90M Reduce
Q2 2024 45.21K $1.88M Add
Q3 2024 104.53K $5.41M Add
Q4 2024 267.65K $15.14M Add
Q1 2025 81.10K $4.95M Reduce
Q2 2025 215.59K $9.98M Add
Q3 2025 229.29K $10.34M Add
Q4 2025 194.48K $10.49M Reduce
Q1 2026 567.38K $34.41M Add
Q2 2026 1.03M $59.54M Add
Q3 2026 1.01M $63.25M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 26 other funds we track also report a position in BMY — the largest reported positions include Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B), AQR Capital Management (US$1.58B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has BI Asset Management Fondsmaeglerselskab A/S held BMY?

BI Asset Management Fondsmaeglerselskab A/S has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BI Asset Management Fondsmaeglerselskab A/S's current position in BMY?

As of Q3 2026, BI Asset Management Fondsmaeglerselskab A/S holds 1.01M shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $63.25M, representing 0.48% of its reported portfolio and ranking #33.

Has BI Asset Management Fondsmaeglerselskab A/S been buying or selling BMY?

In the latest 13F filing (Q3 2026), BI Asset Management Fondsmaeglerselskab A/S reduced its position in BMY. The position peaked in Q3 2026 at 1.01M shares.

Which other funds hold BMY?

Other major institutional holders of BMY include Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, AQR Capital Management, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.